In Vitro Monitoring of Dissolution of an Immediate Release Tablet by Focused Beam Reflectance Measurement
Changes in in vitro drug release profiles of oral dosage forms are commonly observed due to storage of drug product at elevated temperature and humidity. An example is presented of an immediate release drug product which underwent changes to both release profile and crystal form on storage at elevat...
Saved in:
Published in | Molecular pharmaceutics Vol. 7; no. 5; pp. 1508 - 1515 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
04.10.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Changes in in vitro drug release profiles of oral dosage forms are commonly observed due to storage of drug product at elevated temperature and humidity. An example is presented of an immediate release drug product which underwent changes to both release profile and crystal form on storage at elevated humidity. The dissolution rate for unstressed tablets was comparable regardless of the crystal form present. Decreased release rate was only observed for stressed tablets that exhibited crystal form conversion. The cause of the dissolution change was determined by evaluating tablets manufactured with three drug substance crystal forms by fiber optic ultraviolet detection and focused beam reflectance measurement (FBRM). Tablets were also analyzed by near-infrared spectroscopy for crystal form determination. The observed change in dissolution rate correlated with detection of a greater number of larger particles by FBRM. FBRM results indicate increased aggregation of the tablet material due to crystal form conversion, resulting in the presence of slowly disintegrating and dissolving granules during the dissolution process. The improved understanding of the dissolution process allows evaluation of the potential in vivo impact of the stability changes. |
---|---|
AbstractList | Changes in in vitro drug release profiles of oral dosage forms are commonly observed due to storage of drug product at elevated temperature and humidity. An example is presented of an immediate release drug product which underwent changes to both release profile and crystal form on storage at elevated humidity. The dissolution rate for unstressed tablets was comparable regardless of the crystal form present. Decreased release rate was only observed for stressed tablets that exhibited crystal form conversion. The cause of the dissolution change was determined by evaluating tablets manufactured with three drug substance crystal forms by fiber optic ultraviolet detection and focused beam reflectance measurement (FBRM). Tablets were also analyzed by near-infrared spectroscopy for crystal form determination. The observed change in dissolution rate correlated with detection of a greater number of larger particles by FBRM. FBRM results indicate increased aggregation of the tablet material due to crystal form conversion, resulting in the presence of slowly disintegrating and dissolving granules during the dissolution process. The improved understanding of the dissolution process allows evaluation of the potential in vivo impact of the stability changes.Changes in in vitro drug release profiles of oral dosage forms are commonly observed due to storage of drug product at elevated temperature and humidity. An example is presented of an immediate release drug product which underwent changes to both release profile and crystal form on storage at elevated humidity. The dissolution rate for unstressed tablets was comparable regardless of the crystal form present. Decreased release rate was only observed for stressed tablets that exhibited crystal form conversion. The cause of the dissolution change was determined by evaluating tablets manufactured with three drug substance crystal forms by fiber optic ultraviolet detection and focused beam reflectance measurement (FBRM). Tablets were also analyzed by near-infrared spectroscopy for crystal form determination. The observed change in dissolution rate correlated with detection of a greater number of larger particles by FBRM. FBRM results indicate increased aggregation of the tablet material due to crystal form conversion, resulting in the presence of slowly disintegrating and dissolving granules during the dissolution process. The improved understanding of the dissolution process allows evaluation of the potential in vivo impact of the stability changes. Changes in in vitro drug release profiles of oral dosage forms are commonly observed due to storage of drug product at elevated temperature and humidity. An example is presented of an immediate release drug product which underwent changes to both release profile and crystal form on storage at elevated humidity. The dissolution rate for unstressed tablets was comparable regardless of the crystal form present. Decreased release rate was only observed for stressed tablets that exhibited crystal form conversion. The cause of the dissolution change was determined by evaluating tablets manufactured with three drug substance crystal forms by fiber optic ultraviolet detection and focused beam reflectance measurement (FBRM). Tablets were also analyzed by near-infrared spectroscopy for crystal form determination. The observed change in dissolution rate correlated with detection of a greater number of larger particles by FBRM. FBRM results indicate increased aggregation of the tablet material due to crystal form conversion, resulting in the presence of slowly disintegrating and dissolving granules during the dissolution process. The improved understanding of the dissolution process allows evaluation of the potential in vivo impact of the stability changes. |
Author | Doddridge, Greg D Coutant, Carrie A Skibic, Michael J Kemp, Craig A Sperry, David C |
Author_xml | – sequence: 1 givenname: Carrie A surname: Coutant fullname: Coutant, Carrie A email: cacoutant@lilly.com – sequence: 2 givenname: Michael J surname: Skibic fullname: Skibic, Michael J – sequence: 3 givenname: Greg D surname: Doddridge fullname: Doddridge, Greg D – sequence: 4 givenname: Craig A surname: Kemp fullname: Kemp, Craig A – sequence: 5 givenname: David C surname: Sperry fullname: Sperry, David C |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20715796$$D View this record in MEDLINE/PubMed |
BookMark | eNptkE1LAzEQhoMo1q-Df0ByEfRQzcdmP45arRYUQarXZTadlchuUpPswX9vSmsP4mlmeJ8ZmOeQ7FpnkZBTzq44E_y6X3LGeFbkO-SAq0yOS1mJ3W1fZiNyGMInYyJTQu6TkWAFV0WVHxAzs_TdRO_os7MmOm_sB3UtvTMhuG6IxtnVCJbO-h4XBiLSV-wQAtI5NB1G2nzTqdNDwAW9RehT3HaoI1iN9DmBg8cebTwmey10AU829Yi8Te_nk8fx08vDbHLzNAbJVRxzCQx12fBKKaFQiBZYg7xNX2gtpVg0JcOs0ipLednAoi1kWWZYglJ5CuQRuVjfXXr3NWCIdW-Cxq4Di24INReF5DnjVZ7Qsw06NOm5eulND_67_tWTgMs1oL0LwWO7RTirV-rrrfrEXv9htYmwEhg9mO7fjfP1BuhQf7rB2-TlH-4Hc8yQOQ |
CitedBy_id | crossref_primary_10_1111_jphp_12271 crossref_primary_10_3390_pharmaceutics14010208 crossref_primary_10_1016_j_ces_2013_07_013 crossref_primary_10_1016_j_jddst_2023_104891 crossref_primary_10_1007_s11095_011_0535_1 crossref_primary_10_3109_03639045_2014_947508 crossref_primary_10_1016_j_xphs_2020_05_019 crossref_primary_10_1016_j_ijpharm_2024_124778 crossref_primary_10_1016_j_heliyon_2024_e26025 crossref_primary_10_1016_j_susmat_2025_e01341 crossref_primary_10_1080_10837450_2018_1559189 crossref_primary_10_1007_s11095_017_2129_z crossref_primary_10_2174_1573412915666181210144338 crossref_primary_10_1021_acs_cgd_3c01147 crossref_primary_10_1016_j_ijpharm_2020_119838 crossref_primary_10_1002_cjce_23465 |
Cites_doi | 10.1007/s11095-008-9822-x 10.1023/A:1018917729477 10.1016/0731-7085(87)80024-9 10.1002/jps.20818 10.1016/j.ijpharm.2004.08.003 10.1016/j.ces.2008.09.007 10.1201/b14198-3 10.1016/j.ijpharm.2008.08.010 10.1016/S0928-0987(01)00095-1 10.1080/03639040701384918 10.1016/0378-5173(93)90132-Y 10.1016/j.ijpharm.2008.10.010 10.1016/j.ejps.2009.01.008 10.1016/S0378-5173(00)00530-5 10.1021/op049783p 10.1023/A:1018951309506 10.1002/jps.21899 10.1002/jps.10337 10.1021/cg800934h 10.1002/crat.200900402 10.1021/ie800839s |
ContentType | Journal Article |
Copyright | Copyright © 2010 American Chemical Society |
Copyright_xml | – notice: Copyright © 2010 American Chemical Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1021/mp1001476 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Monitoring of Dissolution of an Immediate Release Tablet |
EISSN | 1543-8392 |
EndPage | 1515 |
ExternalDocumentID | 20715796 10_1021_mp1001476 c411198773 |
Genre | Journal Article |
GroupedDBID | - 123 4.4 53G 55A 5VS 7~N AABXI ABMVS ABUCX ACGFS ACS AEESW AENEX AFEFF ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH CS3 DU5 EBS ED ED~ EJD F5P GNL H~9 IH9 JG JG~ LG6 P2P RNS ROL UI2 VF5 VG9 W1F X --- -~X AAYXX ABBLG ABJNI ABLBI ABQRX ADHLV AHGAQ CITATION CUPRZ GGK CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-a315t-13a0ec8b195525e22fa0be1f384cc332db80e49c545528badf73884e8a556e493 |
IEDL.DBID | ACS |
ISSN | 1543-8384 1543-8392 |
IngestDate | Fri Jul 11 09:42:59 EDT 2025 Thu Jan 02 22:36:27 EST 2025 Tue Jul 01 04:33:29 EDT 2025 Thu Apr 24 22:56:45 EDT 2025 Thu Aug 27 13:42:50 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | near-infrared spectroscopy Tablet dissolution focused beam reflectance measurement crystal form dissolution mechanism |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a315t-13a0ec8b195525e22fa0be1f384cc332db80e49c545528badf73884e8a556e493 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 20715796 |
PQID | 1273160196 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1273160196 pubmed_primary_20715796 crossref_primary_10_1021_mp1001476 crossref_citationtrail_10_1021_mp1001476 acs_journals_10_1021_mp1001476 |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N VG9 W1F ACS AEESW AFEFF ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2 CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-10-04 |
PublicationDateYYYYMMDD | 2010-10-04 |
PublicationDate_xml | – month: 10 year: 2010 text: 2010-10-04 day: 04 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Molecular pharmaceutics |
PublicationTitleAlternate | Mol. Pharmaceutics |
PublicationYear | 2010 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | Hersen-Delesalle C. (ref3/cit3) 2007; 33 Costa P. (ref5/cit5) 2001; 13 Han J.-H. (ref14/cit14) 2009; 11 Banakar U. V. (ref7/cit7) 1991; 49 Kamada K. (ref19/cit19) 2009; 368 Barrett P. (ref10/cit10) 2005; 9 Baxter J. L. (ref23/cit23) 2005; 292 ref21/cit21 Patel A. D. (ref20/cit20) 2000; 206 Brits M. (ref8/cit8) 2010; 99 Sarkar D. (ref13/cit13) 2009; 64 Lu A. T. K. (ref6/cit6) 1993; 10 Tajarobi F. (ref16/cit16) 2009; 37 Late S. G. (ref9/cit9) 2009; 365 Rohrs B. R. (ref4/cit4) 1999; 16 Lindenberg C. (ref12/cit12) 2009; 9 Bai G. (ref22/cit22) 2007; 96 Sun Y. Z. (ref15/cit15) 2009; 44 Blanco M. (ref17/cit17) 2003; 92 Gordon M. S. (ref2/cit2) 1993; 97 Kail N. (ref11/cit11) 2009; 48 Gimet R. (ref18/cit18) 1987; 5 Gray V. (ref1/cit1) 2009; 26 |
References_xml | – volume: 26 start-page: 1289 year: 2009 ident: ref1/cit1 publication-title: Pharm. Res. doi: 10.1007/s11095-008-9822-x – volume: 10 start-page: 1308 year: 1993 ident: ref6/cit6 publication-title: Pharm. Res. doi: 10.1023/A:1018917729477 – volume: 5 start-page: 205 year: 1987 ident: ref18/cit18 publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/0731-7085(87)80024-9 – volume: 96 start-page: 2327 year: 2007 ident: ref22/cit22 publication-title: J. Pharm. Sci. doi: 10.1002/jps.20818 – volume: 292 start-page: 17 year: 2005 ident: ref23/cit23 publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2004.08.003 – volume: 64 start-page: 9 year: 2009 ident: ref13/cit13 publication-title: Chem. Eng. Sci. doi: 10.1016/j.ces.2008.09.007 – ident: ref21/cit21 – volume: 11 issue: 2 year: 2009 ident: ref14/cit14 publication-title: AAPS J. – volume: 49 start-page: 19 volume-title: Pharmaceutical dissolution testing year: 1991 ident: ref7/cit7 doi: 10.1201/b14198-3 – volume: 365 start-page: 4 year: 2009 ident: ref9/cit9 publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2008.08.010 – volume: 13 start-page: 123 year: 2001 ident: ref5/cit5 publication-title: Eur. J. Pharm. Sci. doi: 10.1016/S0928-0987(01)00095-1 – volume: 33 start-page: 1297 year: 2007 ident: ref3/cit3 publication-title: Drug Dev. Ind. Pharm. doi: 10.1080/03639040701384918 – volume: 97 start-page: 119 year: 1993 ident: ref2/cit2 publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(93)90132-Y – volume: 368 start-page: 103 year: 2009 ident: ref19/cit19 publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2008.10.010 – volume: 37 start-page: 89 year: 2009 ident: ref16/cit16 publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2009.01.008 – volume: 206 start-page: 63 year: 2000 ident: ref20/cit20 publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(00)00530-5 – volume: 9 start-page: 348 year: 2005 ident: ref10/cit10 publication-title: Org. Process Res. Dev. doi: 10.1021/op049783p – volume: 16 start-page: 1850 year: 1999 ident: ref4/cit4 publication-title: Pharm. Res. doi: 10.1023/A:1018951309506 – volume: 99 start-page: 1138 year: 2010 ident: ref8/cit8 publication-title: J. Pharm. Sci. doi: 10.1002/jps.21899 – volume: 92 start-page: 823 year: 2003 ident: ref17/cit17 publication-title: J. Pharm. Sci. doi: 10.1002/jps.10337 – volume: 9 start-page: 1124 year: 2009 ident: ref12/cit12 publication-title: Cryst. Growth Des. doi: 10.1021/cg800934h – volume: 44 start-page: 1223 year: 2009 ident: ref15/cit15 publication-title: Cryst. Res. Technol. doi: 10.1002/crat.200900402 – volume: 48 start-page: 2936 year: 2009 ident: ref11/cit11 publication-title: Ind. Eng. Chem. Res. doi: 10.1021/ie800839s |
SSID | ssj0024523 |
Score | 2.0491362 |
Snippet | Changes in in vitro drug release profiles of oral dosage forms are commonly observed due to storage of drug product at elevated temperature and humidity. An... |
SourceID | proquest pubmed crossref acs |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1508 |
SubjectTerms | Administration, Oral Biological Availability Chemistry, Pharmaceutical - methods Crystallization Humans Models, Biological Solubility Spectroscopy, Near-Infrared - methods Tablets - administration & dosage Tablets - chemistry Tablets - pharmacokinetics Tablets, Enteric-Coated - administration & dosage Tablets, Enteric-Coated - chemistry Tablets, Enteric-Coated - pharmacokinetics |
Title | In Vitro Monitoring of Dissolution of an Immediate Release Tablet by Focused Beam Reflectance Measurement |
URI | http://dx.doi.org/10.1021/mp1001476 https://www.ncbi.nlm.nih.gov/pubmed/20715796 https://www.proquest.com/docview/1273160196 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT9wwEB5RuPRCW1rotoDMQ4gDoRvHTpwjBVZQCYRgQdwi27GlFWyC2Oxh-fXMJPtoxaPHxHZiecaZL56ZbwC2uQpj1451kIvcBwSpg9SFPlAC7wodEacYRVucxyfX4s-tvJ2DrTc8-Dz81X8gmiCRxB9ggccqoT-sg8OrGaGerGu4IRSIAhUpMaEP-nsomR47-Nf0vIEna7vS-QRHk-ycJpzkbn9YmX379JKs8b0pf4bFMa5kB40ifIE5VyzBzkVDTD3aY91ZntVgj-2wixll9egr9E4LdtOrHkvW7HE67GOlZ0e9qW7SpS7Yab_ONakcu0SDhSaQdSn5qmJmxDqlHQ5czn473cdmTx4BUip2NjuI_AbXnePu4UkwLsIQoKAklarXbWeVCVMpuXSce902KE1caWujiOdGtZ1ILSIxyZXRuU8ihZJWWsoYG6JlmC_Kwn0HlnrnEmcSiyMF99IInyfK4CclVSEOasE6Sikbb6JBVvvHeZhNl7MFuxMBZnZMYU6VNO5f67o57frQ8Ha81mljogUZ7ipylejClUN8NaeKXsQd1IKVRj2mj-GIyiiD98f_pvsTPtaxBhRuIFZhvnocujWEMJVZr1X4Gei_6Fw |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKOcCFN-0CLW6FKg5Nu3HsxDn2wWq3L1WwRb1FtmNLK9ikarKH5dcz42Q3LSqCYxLbGXnGmS_2zDeEfGIyjG0_VkHOcxcgpA5SG7pAcrjLVYScYhhtcREPr_jJtbhuaXIwFwaEqGCkyh_id-wC4f70BtmCeBI_Io8BhDD80To4-tbx6glfyg0QQRTISPIFi9DdruiBTHXfA_0FVnr3Mnje1Cnygvmokh97s1rvmV9_cDb-n-QvyLMWZdKDxixekhVbvCI7lw1N9XyXjrusq2qX7tDLjsB6_ppMRgX9PqlvS9qseNz6o6Wjx5OlpeKlKuho6jNPaku_gvsCh0jHmIpVUz2ng9LMKpvTQ6um8Njh-QCaGD3vtiXfkKvBl_HRMGhLMgSgNoGF61XfGqnDVAgmLGNO9TXoFibcmChiuZZ9y1MDuEwwqVXukkiC3qUSIoYH0VuyWpSFXSc0ddYmVicGenLmhOYuT6SGD0wqQ-jUI5swm1m7pKrMn5azMFtOZ498XugxMy2hOdbV-PlQ0-1l05uGxeOhRlsLY8hgjeHBiSpsOYNXM6zvhUxCPbLWWMlyGAYYDfN53_1L3I_kyXB8fpadjS5O35OnPgoBAxH4B7Ja387sBoCbWm96q_4NdgjwvQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB5BkRAX3o_lUQxCFYembBw7cY6lZdXlUVawrXqLbMeWVu0mqyZ7WH49M0k2C6gIjokfGXnGmbFn5huAN1yFsRvGOshF7gMyqYPUhT5QAt8KHRGmGEVbHMdHJ-LjmTzrDoqUC4NEVDhT1TjxaVcvct8hDITv5gtCDBJJfB1ukLuODlv7B9832HqyKeeGVkEUqEiJNZLQr0NJC9nqdy30F9OyUTGjO_C1J66JLDnfW9Zmz_74A7fx_6m_C7c7a5Ptt-JxD6654j7sTFq46tUum26yr6pdtsMmGyDr1QOYjQt2OqsvS9bufLoCZKVnh7NeYulRF2w8bzJQase-oRpDxcimlJJVM7Nio9IuK5ez907PsdmTn4BEjX3ZXE8-hJPRh-nBUdCVZgiQfZIK2Ouhs8qEqZRcOs69HhrkMS66tVHEc6OGTqQW7TPJldG5TyKF_FdayhgbokewVZSFewIs9c4lziQWRwrupRE-T5TBH02qQhw0gG1c0azbWlXWeM15mPXLOYC3a15mtgM2p_oaF1d1fd13XbRoHld1erUWiAz3GjlQdOHKJX6aU50vQhQawONWUvppONpqlNf79F_kvoSbk8NR9nl8_OkZ3GqCESgeQTyHrfpy6V6gjVOb7UawfwJm0PNA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+monitoring+of+dissolution+of+an+immediate+release+tablet+by+focused+beam+reflectance+measurement&rft.jtitle=Molecular+pharmaceutics&rft.au=Coutant%2C+Carrie+A&rft.au=Skibic%2C+Michael+J&rft.au=Doddridge%2C+Greg+D&rft.au=Kemp%2C+Craig+A&rft.date=2010-10-04&rft.eissn=1543-8392&rft.volume=7&rft.issue=5&rft.spage=1508&rft_id=info:doi/10.1021%2Fmp1001476&rft_id=info%3Apmid%2F20715796&rft.externalDocID=20715796 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1543-8384&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1543-8384&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1543-8384&client=summon |